GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Cryosite CTE.AX · AUD

Health Care · ASX · 🇦🇺 Australia

Compare

1.22

—

Close of 26 Oct 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Cryosite — daily ASX:CTE

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Cryosite on TradingView ↗
Market value
A$60.8m
Last close × shares
Volume
31
Shares, 26 Oct 2026
Price to earnings
27.2

About Cryosite

Its shares trade on ASX under the ticker CTE.AX. It has been listed since 9 May 2002. In the fiscal year to 30 June 2026, it reported revenue of A$16.7m and net income of A$2.2m. At that date it held total assets of A$26.0m and shareholders' equity of A$4.8m.

Cryosite Ltd. engages in the provision of long term storage, supply chain logistics management of pharmaceutical products used in clinical trials and biological materials. The company is headquartered in Sydney, New South Wales. The company went IPO on 2002-05-09. The firm is engaged in cryopreservation and expansion of mesenchymal stem cells (MSCs) from umbilical cord tissue. The firm operates through two segments: Individualised Consumer Biologics, and Scientific Processing and Logistics. The Individualised Consumer Biologics segment provides cord tissue MSC banking to parents, and specialized contract good manufacturing practice (GMP) manufacturing and associated consultancy services to therapeutic and regenerative medicine companies involved in the development and commercialization of technologies. The Scientific Processing and Logistics segment provides specialized commercial drug distribution. The firm also provides specialized bio-repository, clinical trials logistics, commercial drug distribution, contract cellular therapies manufacturing and associated consultancy services to commercial clients both within Australia and internationally.

Figures and description from our data supplier, not checked against the company's own report.

More about Cryosite →

Latest on Cryosite

Our reporting

We have not reported on Cryosite yet.

Next results

25 Feb 2027

Due on 25 Feb 2027. Analysts expect earnings of 0.03 a share.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Cryosite's ticker?

Cryosite trades as CTE.AX on ASX, under ISIN AU000000CTE1.

What was Cryosite's last closing price?

1.22 on 26 Oct 2026. The figure is in AUD and is never converted.

When does Cryosite next report results?

Results are expected on 25 Feb 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.